Table 3 Gene information from iPathwayGuide meta-analysis.

From: Whole genome methylation and transcriptome analyses to identify risk for cerebral palsy (CP) in extremely low gestational age neonates (ELGAN)

 

Gene symbol

Name

Methylation

Log Fold Change; P-value

Gene expression

Log Fold Change; P-value

Functional information

Unique to CP Cases

CSRP1

Cysteine and Glycine Rich Protein 1

− 0.209;

p = 1.000e−6

 + 0.270;

p = 0.015

Gene regulation, cell growth and somatic differentiation; promotes skeletal muscle growth

USP44

Ubiquitin Specific Peptidase 44

 + 0.015;

p = 1.000e–6

 + 0.261;

p = 0.036

Deubiquitinating enzyme; regulates spindle assembly checkpoint by preventing anaphase onset; regulates cell cycle progression and genomic stability

Unique to Controls

CRELB2

cAMP responsive element binding protein like 2

− 0.003;

P = 2.460e−4

− 0.302;

P = 0.010

Protein with DNA binding capabilities; may act as tumor suppressor gene

DCAF11

DDB1 and CUL4 associated factor 11

 + 0.006;

P = 2.900e−5

− 0.469;

P = 9.326e−4

Mediates degradation of stem-loop binding protein, regulates cell cycle/ viability

FEM1A

Fem-1 homolog A

 + 0.007;

P = 2.170e−4

− 0.504;

P = 2.404e−4

Mediates degradation of stem-loop binding protein, regulates cell cycle/ viability

JAK1

Janus kinase 1

− 6.115e−4;

P = 1.370e−4

 + 0.235;

P = 0.044

Protein-tyrosine kinase; key role in interferon-alpha, beta and gamma signal transduction